Particle Counting in Injectable Solutions - Applications Note

This paper discusses the requirements laid out by US (USP), European (EP), and Japanese (JP) Pharmacopoeia standards and includes the most recent USP <788> (USP 42 2018), EP 5.1 and JP 17 release information. These standards demand that injectable solutions are effectively monitored for microcontamination, specifically nonsoluble particulates.